The General Medical Council’s prescribing guidance advises doctors: “As well, you should consider including clinical indications on your prescriptions.” It is paragraph 13 of Good practice in proposing, prescribing, providing and managing medicines and devices, which came into effect on 5 April 2021.
In short
The GMC’s prescribing guidance, in effect since 5 April 2021, advises doctors: “As well, you should consider including clinical indications on your prescriptions.” It is paragraph 13, in the section Keeping up to date and ensuring safe prescribing, and a footnote links to this website. The GMC’s 2013 guidance gave the same advice.
Where is it in the guidance?
In the section Keeping up to date and ensuring safe prescribing. Paragraph 13 reads in full: “You should follow the advice in the BNF on prescription writing and make sure your prescriptions and orders are clear, in accordance with the relevant statutory requirements. You should also make sure you include your name legibly. As well, you should consider including clinical indications on your prescriptions.” A footnote to the words “clinical indications” links to this website.
When did it come into effect?
The guidance was published on 18 February 2021 and came into effect on 5 April 2021. The GMC updated it on 15 March 2022 and again on 13 December 2024.
Did earlier guidance say the same?
Yes. The GMC’s 2013 guidance, Good practice in prescribing and managing medicines and devices, also advised prescribers to consider adding clinical indications to their prescriptions.
This website uses cookies and other tracking technologies to improve your browsing experience for the following purposes: to enable basic functionality of the website, to provide a better experience on the website, to measure your interest in our products and services and to personalize marketing interactions, to deliver ads that are more relevant to you.